UK BROKER RATINGS SUMMARY: National Express Made "ESG Top Pick" Read More
TOP NEWS: Glaxo And Vir's Study Of VIR-7831 In Covid Moves To Phase 3 Read More
UK BROKER RATINGS SUMMARY: Jefferies Cuts Man Group And Jupiter Fund Read More
UK Dividends Calendar - Next 7 Days Read More
UK BROKER RATINGS SUMMARY: Berenberg Says Buy AstraZeneca And Glaxo Read More
GSK Celebrates US Green Light For Blood Disorder Fighting Drug Read More
UK BROKER RATINGS SUMMARY: ODDO BHF Upgrades Astra And Glaxo Read More
GlaxoSmithKline And Sanofi To Supply Canada With Covid-19 Vaccine Read More
Hikma Expects To Gain FDA Approval For Advair Diskus In Early 2021 Read More
LONDON MARKET OPEN: FTSE Bounces Back But Travel Stocks Under Pressure Read More
Positive EU Committee Opinion For GlaxoSmithKline's Zejula Read More
TOP NEWS: Sanofi, Glaxo Finalise Covid-19 Vaccine Supply Pact With EU Read More
GlaxoSmithKline Gains FDA Approval For Trelegy Use As Asthma Treatment Read More
UK BROKER RATINGS SUMMARY: Barclays Cuts GVC And Raises Flutter Read More
Sanofi And Glaxo Aim For December Start For Phase 3 Of Vaccine Trial Read More
IN BRIEF: GlaxoSmithKline And Vir Dose First Patient In Covid-19 Trial Read More
GlaxoSmithKline Reports Positive Data From Hepatitis B Drug Trial Read More
European Regulator Approves Glaxo's Blood Cancer Treatment Blenrep Read More
Denmark Signs Up For EU's AstraZeneca Coronavirus Vaccine Deal Read More
TOP NEWS: Glaxo Vaccinates First Participant In Meningitis ABCWY Trial Read More
